Literature DB >> 1732555

Chromophore-modified antineoplastic imidazoacridinones. Synthesis and activity against murine leukemias.

W M Cholody1, S Martelli, J Konopa.   

Abstract

The synthesis of 8-hydroxy and 8-methoxy analogues of some substituted 5-aminoimidazoacridinones (4) is described. The synthesis was carried out by a three-step sequence from the corresponding 1-chloro-4-nitro-9(10H)-acridinone precursors (1). The annulation of the imidazolo ring onto the aminoacridinone chromophore was accomplished by heating the required aminoacridinone (3) with formic acid or, in the case of 1-methyl derivatives, with N,N-dimethylacetamide. Potent cytotoxic activity against L1210 leukemia, as well as antitumor activity against P388 leukemia in mice, was demonstrated for the 8-hydroxy analogues. The corresponding 8-methoxy derivatives were not cytotoxic. However, in some cases, they showed significant in vivo antileukemic activity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1732555     DOI: 10.1021/jm00080a026

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  6 in total

1.  Role of human UDP-glucuronosyltransferases in the biotransformation of the triazoloacridinone and imidazoacridinone antitumor agents C-1305 and C-1311: highly selective substrates for UGT1A10.

Authors:  Barbara Fedejko-Kap; Stacie M Bratton; Moshe Finel; Anna Radominska-Pandya; Zofia Mazerska
Journal:  Drug Metab Dispos       Date:  2012-06-01       Impact factor: 3.922

2.  Chemotherapeutic potential of 9-phenyl acridine: biophysical studies on its binding to DNA.

Authors:  Rita Ghosh; Sudipta Bhowmik; Angshuman Bagchi; Dipankar Das; Somnath Ghosh
Journal:  Eur Biophys J       Date:  2010-02-05       Impact factor: 1.733

3.  Cell killing by the novel imidazoacridinone antineoplastic agent, C-1311, is inhibited at high concentrations coincident with dose-differentiated cell cycle perturbation.

Authors:  J Lamb; D N Wheatley
Journal:  Br J Cancer       Date:  1996-11       Impact factor: 7.640

4.  CYP3A4 overexpression enhances apoptosis induced by anticancer agent imidazoacridinone C-1311, but does not change the metabolism of C-1311 in CHO cells.

Authors:  Monika Pawłowska; Ewa Augustin; Zofia Mazerska
Journal:  Acta Pharmacol Sin       Date:  2013-12-02       Impact factor: 6.150

5.  Physicochemical interaction of antitumor acridinone derivatives with DNA in view of QSAR studies.

Authors:  Marcin Koba; Tomasz Bączek
Journal:  Med Chem Res       Date:  2010-11-17       Impact factor: 1.965

6.  Cellular uptake, cytotoxicity and DNA-binding studies of the novel imidazoacridinone antineoplastic agent C1311.

Authors:  A M Burger; T C Jenkins; J A Double; M C Bibby
Journal:  Br J Cancer       Date:  1999-09       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.